Full Paper
[3]
a) X. Verdaguer, U. E. W. Lange, M. T. Reding, S. L. Buchwald, J. Am. Chem.
Soc. 1996, 118, 6784; b) N. Langlois, T. P. Dang, H. B. Kagan, Tetrahedron
Lett. 1973, 14, 4865; c) R. Becker, H. Brunner, S. Mahboobi, W. Wiegrebe,
Angew. Chem. Int. Ed. Engl. 1985, 24, 995; Angew. Chem. 1985, 97, 969;
d) Y. Nishibayshi, I. Takei, S. Uemura, M. Hidai, Organometallics 1998, 17,
3420; e) K. A. Nolin, R. W. Ahn, F. D. Toste, J. Am. Chem. Soc. 2005, 127,
12462.
(SS)-2-Methyl-N-[(S)-(2E,3E)-4-phenylbut-3-en-2-yl]propane-2-
1
sulfinamide (2k):[9] Colorless oil (88 mg, 70 %). H NMR (600 MHz,
CDCl3): δ = 7.39–7.24 (m, 5 H), 6.58 (dd, J = 15.9, 8.3 Hz, 1 H), 6.21
(dd, J = 15.9, 7.2 Hz, 1 H), 4.14–4.11 (m, 1 H), 3.24 (d, J = 4.1 Hz, 1
H), 1.39 (d, J = 6.5 Hz, 3 H), 1.23 (s, 9 H) ppm. 13C NMR (151 MHz,
CDCl3): δ = 136.5, 132.1, 130.9, 128.6, 127.8, 126.5, 55.5, 53.0, 22.6,
21.4 ppm. IR: ν = 3196, 2959, 1052, 962, 747, 692 cm–1. [α]D25 = +12.3
˜
[4]
[5]
D. Łowicki, S. Baś, J. Mlynarski, Tetrahedron 2015, 71, 133.
(c = 1.0, CHCl3), 64 % de.
a) H. Mimoun, J. Y. de Saint Laumer, L. Giannini, R. Scopelliti, C. Floriani,
J. Am. Chem. Soc. 1999, 121, 6158; for recent examples of a Zn-based
asymmetric hydrosilylation of ketones, see: b) M. Szewczyk, F. Stanek, A.
Bezłada, J. Mlynarski, Adv. Synth. Catal. 2015, 357, 3727; c) D. Łowicki, A.
Bezłada, J. Mlynarski, Adv. Synth. Catal. 2014, 356, 591; d) F. S. Pang, J.
Peng, J. Li, Y. Bai, W. Xiao, G. Lai, Chirality 2013, 25, 275; e) K. Junge, K.
Moller, B. Wendt, S. Das, D. Gordes, K. Thurow, M. Beller, Chem. Asian J.
2012, 7, 314; f) T. Inagaki, Y. Yamada, L. T. Phong, A. Furuta, J.-I. Ito, H.
Nishiyama, Synlett 2009, 253; for recent examples of an Fe-based asym-
metric hydrosilylation of ketones, see: g) T. Bleith, H. Wadepohl, L. Gade,
J. Am. Chem. Soc. 2015, 137, 2456; h) Z. Zuo, L. Zhang, X. Leng, Z. Huang,
Chem. Commun. 2015, 51, 5073; i) M. Flückiger, A. Togni, Eur. J. Org.
Chem. 2011, 4353; j) S. Hosokawa, J.-I. Ito, H. Nishiyama, Organometallics
2010, 29, 5773.
a) V. Bette, A. Mortreux, D. Savoia, J. F. Carpentier, Adv. Synth. Catal. 2005,
347, 289; b) B. M. Park, S. Mun, J. Yun, Adv. Synth. Catal. 2006, 348, 1029;
c) M. Bandini, M. Melucci, F. Piccinelli, R. Sinisi, S. Tommasi, A. Umani-
Ronchi, Chem. Commun. 2007, 4519; d) B. M. Park, X. Feng, J. Yun, Bull.
Korean Chem. Soc. 2011, 32, 2960; e) J. Gajewy, J. Gawronski, M. Kwit,
Org. Biomol. Chem. 2011, 9, 3863; f) for a review, see: O. Riant, N. Moste-
fai, J. Courmarcel, Synthesis 2004, 18, 2943; for zinc-catalyzed reductions
of amides, see: g) S. Das, D. Addis, S. Zhou, K. Junge, M. Beller, J. Am.
Chem. Soc. 2010, 132, 1770; for zinc-catalyzed reductive aminations, see:
h) S. Enthaler, Catal. Lett. 2011, 141, 55.
(SS)-2-Methyl-N-[(S)-1-(1-naphthyl)ethyl]propane-2-sulfinamide
1
(2l):[24] Colorless oil (107 mg, 78 %). H NMR (600 MHz, CDCl3): δ =
8.23 (d, J = 8.5 Hz, 1 H), 7.88–7.80 (m, 2 H), 7.62–7.47 (m, 4 H), 5.38
(qd, J = 6.4, 1.7 Hz, 1 H), 3.60 (s, 1 H), 1.70 (d, J = 6.5 Hz, 3 H), 1.24
(s, 9 H) ppm. 13C NMR (151 MHz, CDCl3): δ = 139.2, 134.0, 130.5,
129.0, 128.5, 126.5, 125.8, 125.44, 123.5, 123.1, 55.5, 49.3, 22.7,
21.8 ppm. IR: ν = 3216, 2976, 1594, 1055, 775 cm–1. [α]D25 = +90.7
˜
(c = 1.0, CHCl3), 93 % de.
(SS)-Ethyl 2-[(S)-1,1-Dimethylethylsulfinamido]-2-phenylacetate
1
(2m):[23] Colorless oil (77 mg, 54 %). H NMR (600 MHz, CDCl3): δ =
7.38–7.32 (m, 5 H), 5.06 (d, J = 4.4 Hz, 1 H), 4.59 (d, J = 4.2 Hz, 1 H),
4.26–4.21 (m, 1 H), 4.16–4.11 (m, 1 H), 1.24 (s, 9 H), 1.20 (t, J =
7.1 Hz, 3 H) ppm. 13C NMR (151 MHz, CDCl3): δ = 171.4, 137.3, 128.7,
[6]
128.4, 127.7, 62.2, 60.5, 60.0, 22.6, 14.0 ppm. IR: ν = 3282, 3184,
˜
2980, 1737, 1455, 1292, 1178, 1070, 848 cm–1. [α]D25 = +158.2 (c =
1.0, CHCl3), 75 % de.
Procedure for the Removal of the N-tert-Butylsulfinyl Group of
Representative Compound 2a: The optical purity of compound
2a (Table 3, Entry 1, 91 % de) was confirmed by the optical rotation
of the corresponding chiral amine (1-phenylethylamine) using a
[7]
[8]
polarimeter. To
ethyl]propane-2-sulfinamide (112 mg, 0.5 mmol) in MeOH (0.20 mL)
was added HCl (1.25 ) in MeOH (0.8 mL, 1.0 mmol) at room tem-
a
solution of (SS)-2-methyl-N-[(S)-1-phenyl-
a) J. A. Ellman, T. D. Owens, T. P. Tang, Acc. Chem. Res. 2002, 35, 984; b)
J. A. Ellman, Pure Appl. Chem. 2003, 75, 39; c) P. Zhou, B.-C. Chen, F. A.
Davis, Tetrahedron 2004, 60, 8003; d) G.-Q. Lin, M.-H. Xu, Y.-W. Zhong, X.-
W. Sun, Acc. Chem. Res. 2008, 41, 831; e) F. Ferreira, C. Botuha, F. Chemla,
A. Perez-Luna, Chem. Soc. Rev. 2009, 38, 1162; f) P. Zhou, B.-C. Chen, F. A.
Davis, Tetrahedron 2004, 60, 8003.
a) X. Sun, S. Wang, S. Sun, J. Zhu, J. Deng, Synlett 2005, 2776; b) A.
Kosciolowicz, M. D. Rozwadowska, Tetrahedron: Asymmetry 2006, 17,
1444; c) B. Denolf, S. Mangelinckx, K. W. Toernroos, N. De Kimpe, Org.
Lett. 2006, 8, 3129.
G. Borg, D. A. Cogan, J. A. Ellman, Tetrahedron Lett. 1999, 40, 6709.
J. Tanuwidjaja, J. Peltier, J. A. Ellman, J. Org. Chem. 2007, 72, 626.
C.-H. Zhao, L. Liu, D. Wang, Y.-J. Chen, Eur. J. Org. Chem. 2006, 2977.
a) G. Dutheuil, S. Couve-Bonnaire, X. Pannecoucke, Angew. Chem. Int. Ed.
2007, 46, 1290; Angew. Chem. 2007, 119, 1312; b) Z.-J. Liu, J.-T. Liu, Chem.
Commun. 2008, 5233; c) J. T. Colyer, N. G. Andersen, J. S. Tedrow, T. S.
Soukup, M. M. Faul, J. Org. Chem. 2006, 71, 6859.
M
perature. The mixture was stirred for 30 min and then extracted
with diethyl ether. The aqueous phase was basified with NaOH solu-
tion and extracted again with diethyl ether. The combined organic
phases were dried with Na2SO4 and evaporated under reduced
pressure to give the corresponding (S)-(–)-1-phenylethylamine
(59 mg, 97 %) as a pure pale yellow oil. [α]D25= –30.6, (c = 1.0, CHCl3);
ref.[25] [α]D29= –36.7, (c = 1.02, CHCl3), 99 % ee. All spectroscopic data
are in agreement with previously reported values for the amine
product.[25]
[9]
[10]
[11]
[12]
Supporting Information (see footnote on the first page of this
article): 1H and 13C NMR spectra as well as HPLC analysis of pro-
ducts.
[13]
[14]
X. Xiao, H. Wang, Z. Huang, J. Yang, X. Bian, Y. Qin, Org. Lett. 2006, 8,
139.
Acknowledgments
a) D. Guijarro, O. Pablo, M. Yus, Tetrahedron Lett. 2009, 50, 5386; b) D.
Guijarro, O. Pablo, M. Yus, J. Org. Chem. 2010, 75, 5265; c) D. Guijarro, O.
Pablo, M. Yus, Tetrahedron Lett. 2011, 52, 789; d) O. Pablo, D. Guijarro, G.
Kovacs, A. Lledós, G. Ujaque, M. Yus, Chem. Eur. J. 2012, 18, 1969; e) D.
Guijarro, O. Pablo, M. Yus, Org. Synth. 2013, 90, 338; f) D. Guijarro, O.
Pablo, M. Yus, J. Org. Chem. 2013, 78, 3647; g) O. Pablo, D. Guijarro, M.
Yus, J. Org. Chem. 2013, 78, 9181; h) O. Pablo, D. Guijarro, M. Yus, Eur. J.
Org. Chem. 2014, 75, 7034.
Financial support from the Polish National Science Centre (grant
number NCN 2012/07/B/ST5/00909) is gratefully acknowledged.
Keywords: Asymmetric synthesis · Diastereoselectivity ·
Amines · Hydrosilylation · Zinc
[15]
[16]
[17]
a) C. M. Spencer, S. Noble, Drugs Aging 1998, 13, 391–411; b) C. Bhanja,
S. Jena, J. Chem. Pharm. Res. 2012, 4, 3171.
G. Tsuji, T. Takeda, I. Furusawa, O. Horino, Y. Kubo, Pestic. Biochem. Physiol.
1997, 57, 211.
N. Franceschini, M. S. Joy, A. Kshirsagar, Expert Opin. Invest. Drugs 2003,
12, 1413.
[1] B. Marciniec (Ed.), Hydrosilylation: A Comprehensive Review on Recent Ad-
vances, Springer, The Netherlands, 2009, p. 342–398.
[2] a) T. C. Nugent (Ed.), Chiral Amine Synthesis, Wiley-VCH, Weinheim, Ger-
many, 2010; b) T. C. Nugent, M. El-Shazly, Adv. Synth. Catal. 2010, 352,
753; for a review of the asymmetric hydrogenation of imines and
heteroaromatic compounds, see: c) J.-H. Xie, S.-F. Zhu, Q.-L. Zhou, Chem.
Rev. 2011, 111, 1713; d) Y.-G. Zhou, Acc. Chem. Res. 2007, 40, 1357; for a
review of the asymmetric transfer hydrogenation of imines, see: e) F.
Foubelo, M. Yus, Chem. Rec. 2015, 15, 907.
[18]
[19]
[20]
Q. Chen, C. Yuan, Synthesis 2007, 24, 3779.
D. Zhang, C. Yuan, Chem. Eur. J. 2008, 14, 6049.
Shionogiand Co., Ltd., Patent: EP2147914 A1, 2010.
Eur. J. Org. Chem. 2016, 1060–1065
1064
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim